Compounds > y 27632
Page last updated: 2024-09-03

y 27632 and Nerve Degeneration

y 27632 has been researched along with Nerve Degeneration in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cardona-Gómez, GP; Castro-Alvarez, JF; Darnaudéry, M; Gutierrez-Vargas, J1
Chou, AH; Hu, SH; Wang, HL; Wang, SS; Weng, YH; Yeh, TH1
Agrawal, N; Apostol, BL; Bodai, L; Chang, LW; Chiang, AS; Marsh, JL; Pallos, J; Slepko, N; Thompson, LM1

Other Studies

3 other study(ies) available for y 27632 and Nerve Degeneration

ArticleYear
ROCK inhibition prevents tau hyperphosphorylation and p25/CDK5 increase after global cerebral ischemia.
    Behavioral neuroscience, 2011, Volume: 125, Issue:3

    Topics: Amides; Animals; Brain Ischemia; Cyclin-Dependent Kinase 5; Disease Models, Animal; DNA-Binding Proteins; Enzyme Inhibitors; Hippocampus; Injections, Intraventricular; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; Spatial Behavior; tau Proteins

2011
H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Neuropharmacology, 2013, Volume: 70

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Ataxin-3; Ataxin-7; Brain; Dose-Response Relationship, Drug; Gene Expression; Humans; Indazoles; Mice; Mice, Transgenic; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Niacinamide; Nuclear Proteins; Peptides; Proteasome Endopeptidase Complex; Pyridines; rho-Associated Kinases; Transcription Factors

2013
Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Mar-08, Volume: 102, Issue:10

    Topics: Amides; Animals; Benzoquinones; Disease Models, Animal; Drosophila; Drug Therapy, Combination; Female; Huntington Disease; Hydroxamic Acids; Lactams, Macrocyclic; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Pyridines; Quinones; Vorinostat

2005